Wednesday 7 September 2016

Global Mobility Scooter Market Size, Share and Forecast Up to 2024

Mobility scooters are electronic transport vehicles used as a mobility aid, mostly occupied by single person. These mobility scooters are operated on battery and varies from 3 wheels to 5 wheels. Mobility scooters assist in the movement of a person from one place to another, especially long distance travelling. Gasoline-powered scooters are very rare in the market and are being rapidly replaced by electric or battery-powered scooters. Mobility scooters are available in two forms worldwide: front-wheel drive and rear-wheel drive. Front-wheel drive scooters are smaller and are primarily used indoors, whereas the rear-wheel drive scooters are used both outdoors and indoors. The rider weight capacity of a rear-wheel drive scooter is higher than the front-wheel drive scooter. Mobility scooters acts as an alternative to wheelchairs and is expected to have a significant growth rate during the forecast period from 2016-2024. The use of mobility scooters are supported with government funding in most of the regions across the globe. However, comparative high cost than wheelchairs is likely to hinder the growth of the market segment. Thus, the government interventions has made the use of mobility scooter cost effective through various schemes offered to the users. The mobility scooters offers comfort, ease of use and elegance, which instead is not offered by traditional wheelchairs, makes the mobility scooter market more potential. 


Moreover, rising geriatric population, increasing incidences of knee and spine disorders, rising accidental and innate deformities are the important factors leading to the growing demand for mobility scooters globally. In order to assist the research and development in mobility aids, various national and international organizations participate actively along with regional government. Various government initiatives such as Affordable Care Act in the U.S., offers subsidy on mobility scooters for patients. Thus, market has high potential to grow in terms of its population reach, which is actively supported by government and non-government bodies. In addition, availability of mobility scooters in different designs and features has increased the attention of users towards mobility scooters. However, lack of infrastructure in many parts of the world and high cost of the devices restricts the uptake to some extent. Moreover, the use of refurbished mobility scooters is another biggest challenge faced by the market.

The mobility scooter market can be segmented into by type of design, by number of wheels, by distribution channel and by geography. In the terms of design, the mobility scooter is classified into boot scooters, mid-sized scooters and on road scooters. By wheels, the mobility scooter is classified into 3 wheels, 4 wheels and 5 wheels mobility scooters. By geography, the U.S. and European regions mainly U.K., occupies significant share of the mobility scooter market. North America dominates the market, due to government policies and high demand for mobility scooters. Moreover, baby boomer effect, sophisticated reimbursement policies, high awareness about the device are the other key factors favoring the market in North America. Followed by North America, Europe accounted for the second largest share of the global mobility scooters market due to increasing awareness and rising disposable income. However, Asia Pacific is expected to grow at a higher growth rate owing to huge untapped population and increasing health care awareness among the patient population.

The major players having presence in the global mobility scooters market include Invacare, Afikim Electric Vehicles., Drive Medical Design and Manufacturing, Golden Technologies Inc., Pride Mobility Products, Hoveround Corp., Sunrise Medical, Van Os Medical, Electric Mobility, Amigo Mobility International Inc., Quingo, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape. 

Browse Research Report on Global Mobility Scooter Market:
http://www.transparencymarketresearch.com/mobility-scooter-market.html

Friday 2 September 2016

Modern Tech Lends Helping Hand to Global Compression Therapy Market Growth

Inadequate regulations for the commercialization of products and forward integration by raw material suppliers have kept the threat of new entrants high in the global compression therapy market, finds Transparency Market Research in a new study. This, combined with presence of a large number of local and global players, renders the market highly fragmented. Suppliers in the market also don’t enjoy a high bargaining power due to their presence in large numbers.


The majority of the companies operating in the market are vying to emerge dominant through mergers and acquisitions. They are also witnessing attractive prospects in the emerging economies of Asia Pacific. TMR recommends that adopting collaborative strategies could help these companies capitalize on untapped opportunities in the region. With the population in China, Japan, Singapore, and South Korea increasing at a rapid pace, combined with their increasing interest in sports and fitness, manufacturers of compression therapy products stand chance to gain a competitive edge in the market.

Capitalizing on Untapped Opportunities in Emerging Economies Could Boost Market

TMR finds that the ripest opportunities lie in emerging economies of Latin America and Asia Pacific. “Immense potential for healthcare products in countries such as South Korea, Brazil, China, Mexico, and India will prove to be lucrative for companies vying for sizeable share in the global compression therapy market,” said a TMR analyst. “Due to the increasing investment on the healthcare infrastructure, increasing disposable income, and the rising incidence of chronic ailments, these regions exhibit robust prospects for the compression therapy market,” he added.

In the last few years, compression therapy has emerged as one of the most preferred procedures for treating sports related injuries. The growth witnesses by the market therefore corresponds directly to the growing popularity for sports worldwide. Besides this, the rising prevalence of obesity and increase in the number of orthopedic surgeries also create ample opportunities favoring the market’s expansion.

Absence of Reimbursement Regulations to Negatively Impact Sales of Compression Therapy Products

Despite growth prospects for the market being robust, the absence of proper reimbursement will have an adverse impact on its growth trajectory. Nevertheless, the increasing investment on the development of the healthcare infrastructure in developing companies will provide considerable opportunities for vendors to boost their sales.

Presently, the market has been witnessing lucrative prospects for the sale of static compression products. Supported by clinical evidence, static garments are preferred more by doctors as patient care products. Additionally, patients favor static compression hosiery more since it is made with comfortable material and due to its aesthetic appeal.

North America Exhibits Highest Prospects for Compression Therapy

Regionally, the prospects for compression therapy seem most lucrative in North America. The region held over 47.2% of the global compression therapy market in 2015, followed by Europe, which accounted for a share of 32.2% in the market. Obesity being a widespread problem in developed economies such as the U.S., North America will be witnessing a high incidence of vascular diseases. This is evidently proving favorable for enterprises offering compression therapy products to maximize their sales.

Transparency Market Research forecasts the global compression therapy market to reach US$4.25 bn by 2024 from a valuation of US$2,693.4 mn in 2015. If these figures hold true, the market will exhibit a CAGR of 5.3% between 2016 and 2024.

Browse Research Report on Global Compression Therapy Market:
http://www.transparencymarketresearch.com/compression-therapy-market.html

Thursday 1 September 2016

Nonalcoholic Steatohepatitis Therapeutics Market to Reach US$20.27 bn by 2025

According to a new market report published by Transparency Market Research “Nonalcoholic Steatohepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2025”, the nonalcoholic steatohepatitis (NASH) therapeutics market is anticipated to expand at a CAGR of 10.7% from 2015 to 2025 to reach US$20.27 bn by 2025.

Request a Free PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7691
 
Nonalcoholic Steatohepatitis (NASH) is a syndrome that advances in patients who are not alcoholic; it causes liver damage that is histologically indistinguishable from alcoholic hepatitis. The major feature in NASH is fat in the liver, along with inflammation and damage. Most people with NASH feel well and are not aware of their liver problem. However, NASH can be severe and can lead to cirrhosis, in which the liver is permanently damaged and no longer able to work properly. It develops most frequently in patients with at least one of the following risk factors as obesity, dyslipidemia, and glucose intolerance. Pathogenesis is not clearly understood but seems to be linked to insulin resistance. Most of the patients are asymptomatic. Laboratory outcomes include elevations in aminotransferase levels. Biopsy is essential to confirm the diagnosis. Treatment mainly focusses on elimination of causes and risk factors. 

The prevalence of NASH and NAFLD is increasing across the globe but it is more in developed regions such as North America. Both NASH and NAFLD are becoming more common, perhaps because of the greater number of Americans with obesity. In the past few years, the rate of obesity has almost doubled in adults and tripled in children. Obesity also adds to diabetes and high blood cholesterol, which can further complicate the health of people suffering from NASH. Diabetes and high blood cholesterol are also becoming more common among Americans. 

Currently, no specific therapies exist for NASH treatment. The most important recommendations given to persons with this disease are weight reduction (if overweight), following a balanced and healthy diet, increasing physical activity, avoiding alcohol and avoiding unnecessary medications. 

The NASH market is segmented based on drug type which includes potential phase III candidates such as Obeticholic acid (OCA), Aramchol, Saroglitazar and Elafibranor. Moreover, the report enlists the candidates in Phase I and Phase II clinical trials. Based on the drug type, Elafibranor is expected to account for a major share of this market and the market for Elafibranor is expected to grow at the highest CAGR. This growth is majorly due to Elafibranor which is considered to be the most advanced drug in this category. 

Major players in this market are Astazeneca Plc (U.K.), Intercept Pharmaceuticals Inc. (U.S.), Galmed Pharmaceuticals Ltd. (Israel), GENFIT SA (France), Gilead Sciences, Inc. (U.S.), Zydus Cadila (India), Immuron Ltd. (Australia), Conatus Pharmaceuticals (U.S.), and Tobira Therapeutics, Inc. (U.S.).  

Browse Research Report on Global Nonalcoholic Steatohepatitis Therapeutics Market:
http://www.transparencymarketresearch.com/nonalcoholic-steatohepatitis-market.html